Mississippi has approximately 120 licensed substance abuse treatment facilities and recorded over 750 drug overdose deaths in 2023. The state faces significant treatment access challenges, with many rural counties having no local treatment facilities. The Mississippi Department of Mental Health (DMH) oversees the state's publicly funded behavioral health system, operating two state-run treatment facilities and contracting with 15 regional community mental health centers.
Substance Abuse Statistics in Mississippi
According to NSDUH data, approximately 6.8% of Mississippi adults reported a substance use disorder in the past year. While Mississippi's overall overdose death rate is lower than many neighboring states, fentanyl-involved fatalities have increased dramatically — more than tripling between 2019 and 2023. Methamphetamine remains the most commonly cited substance in treatment admissions, particularly in rural areas.
Alcohol is the most commonly misused substance overall, accounting for approximately 28% of all treatment admissions. Prescription opioid misuse remains a concern, though prescribing rates have declined due to tighter regulations. Mississippi has also seen increases in cocaine and synthetic drug use, particularly in the Jackson metro area and along the Gulf Coast.
Types of Treatment Programs Available
Medical Detox: Medically supervised detox is available in Jackson, Gulfport-Biloxi, Hattiesburg, and a few other larger cities. DMH operates crisis stabilization units that provide detox services. Access in rural Delta and Appalachian regions is severely limited.
Residential/Inpatient Treatment: DMH operates two state-run residential treatment facilities and contracts with additional community-based providers. Private residential facilities offer 28-day to 90-day programs. Total residential capacity is limited relative to the state's needs, with long wait times common for state-funded beds.
Outpatient Programs: IOPs and standard outpatient services are available through 15 regional community mental health centers and private providers. Mississippi Medicaid covers outpatient SUD services for eligible populations including counseling, case management, and peer support.
Medication-Assisted Treatment (MAT): Mississippi has approximately 25 Opioid Treatment Programs and a growing but still insufficient number of buprenorphine prescribers. DMH has focused on expanding MAT access through its community mental health centers. Mississippi Medicaid covers methadone (through OTPs), buprenorphine, and naltrexone.
Treatment Access Challenges
Mississippi ranks near the bottom nationally in treatment capacity per capita. The state's large rural geography — particularly the Mississippi Delta and hill country — presents significant barriers to treatment access. Many counties have no residential treatment facilities and limited outpatient options. DMH has been working to expand telehealth-based SUD services and mobile crisis capabilities to reach underserved areas, but significant gaps remain.
Insurance & Payment Options
Medicaid: Mississippi has not expanded Medicaid under the ACA. Mississippi Medicaid covers SUD treatment for eligible populations (children, pregnant women, low-income parents, elderly, disabled) including outpatient counseling, MAT, and limited residential services.
Private Insurance: Major carriers including Blue Cross Blue Shield of Mississippi, UnitedHealthcare, Humana, and Molina cover SUD treatment under federal parity requirements. Verify your insurance to check your coverage.
State-Funded Programs: DMH funds treatment through 15 regional community mental health centers. Uninsured individuals can access services on a sliding-fee scale through these centers.
Finding Help in Mississippi
SAMHSA National Helpline: Call 1-800-662-4357 for free, confidential, 24/7 referrals.
MS DMH Helpline: Call 1-877-210-8513 for substance abuse referral services and crisis support across Mississippi.
211 Mississippi: Dial 211 for local resource referrals including treatment programs, support groups, and emergency services.